25 May 2013
Keywords: intercell, acquire, remainder, pelias, germany, ag, agreed
Article | 11 December 2006
Germany's Intercell AG has agreed to up its 46% stake in the Vienna-based Pelias Biomedical Development AG to gain 100% ownership.
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
11 December 2006
24 May 2013
© 2013 thepharmaletter.com